Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 19 Jun 2024

Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy

in Hematologic Malignancies

José Luis Piñana
Lourdes Vazquez
Inmaculada Heras
Tommaso Francesco Aiello
Lucia López-Corral
Ignacio Arroyo
Eva Soler-Espejo
Irene García-Cadenas
Valentín Garcia-Gutierrez
Cristina Aroca

Frontiers in Oncology

doi 10.3389/fonc.2024.1389345

2,174 views
2 citations

Original Research

Published on 13 Jun 2024

No advantage of antimicrobial prophylaxis in AML/MDS/CMML patients treated with azacitidine—a prospective multicenter study by the Polish Adult Leukemia Group

in Hematologic Malignancies

Krzysztof Mądry
Karol Lis
Elzbieta Sienkiewicz
Joanna Drozd-Sokołowska
Przemysław Biecek
Oktawia Sośnia
Aleksandra Gołos
Magdalena Olszewska-Szopa
Agata Obara
Zuzanna Walkowiak

Frontiers in Oncology

doi 10.3389/fonc.2024.1404322

1,992 views

Case Report

Published on 13 Jun 2024

Case report: Clinical features of pediatric acute myeloid leukemia presenting with cardiac tamponade: a case series study and literature review

in Hematologic Malignancies

Tonghui Li
Xue Tang
Xuezhi He
Lei Zhang
Ya Zhang
Lulu Wang
Shilin Liu
Guichi Zhou
Feiqiu Wen
Sixi Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1391768

1,317 views

Original Research

Published on 13 Jun 2024

Complete elimination of hyperleukocytosis risk in AML through early high-quality disease remission

in Hematologic Malignancies

Guoqing Lyu
Wenting Lyu

Frontiers in Oncology

doi 10.3389/fonc.2024.1412583

1,488 views
1 citation

Original Research

Published on 11 Jun 2024

Risk score constructed with neutrophil extracellular traps-related genes predicts prognosis and immune microenvironment in multiple myeloma

in Hematologic Malignancies

Gongzhizi Gao
Rui Liu
Dong Wu
Dandan Gao
Yang Lv
Xuezhu Xu
Bingjie Fu
Zujie Lin
Ting Wang
Aili He

Frontiers in Oncology

doi 10.3389/fonc.2024.1365460

2,234 views

Review

Published on 11 Jun 2024

Late events after anti-CD19 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma

in Hematologic Malignancies

Ana Costa Cordeiro
George Durisek
Marjorie Vieira Batista
Jayr Schmidt
Marcos de Lima
Evandro Bezerra

Frontiers in Oncology

doi 10.3389/fonc.2024.1404351

3,161 views
1 citation

Original Research

Published on 11 Jun 2024

Lipid have a direct effect on multiple myeloma: a Mendelian randomization study

in Hematologic Malignancies

Yingbin Zhong
Yanhao Li
Weipeng Sun
Mingfeng Xiao

Frontiers in Oncology

doi 10.3389/fonc.2024.1404744

2,786 views

Original Research

Published on 06 Jun 2024

Performance of MYC, BCL2, and BCL6 break-apart FISH in small biopsies with large B-cell lymphoma: a retrospective Cytopathology Hematopathology Interinstitutional Consortium study

in Hematologic Malignancies

Joshua R. Menke
Umut Aypar
Charles D. Bangs
Stephen L. Cook
Srishti Gupta
Robert P. Hasserjian
Christina S. Kong
Oscar Lin
Steven R. Long
Amy Ly

Frontiers in Oncology

doi 10.3389/fonc.2024.1408238

2,130 views

Review

Published on 05 Jun 2024

The treatment of follicular lymphoma with CD19-directed chimeric antigen receptor T-cell therapy

in Hematologic Malignancies

Ryan Jacobs
Caron Jacobson

Frontiers in Oncology

doi 10.3389/fonc.2024.1384600

2,709 views

Review

Published on 04 Jun 2024

Allogeneic stem cell transplantation in multiple myeloma: is there still a place?

in Hematologic Malignancies

Carmine Liberatore
Francesca Fioritoni
Mauro Di Ianni

Frontiers in Oncology

doi 10.3389/fonc.2024.1402106

2,671 views
1 citation

Editorial

Published on 03 Jun 2024

Editorial: Checkpoint inhibition in hematologic malignancies

in Hematologic Malignancies

Jeffrey J. Pu
Joseph J. Drabick
Susan E. Prockop

Frontiers in Oncology

doi 10.3389/fonc.2024.1429854

838 views

Original Research

Published on 31 May 2024

LINC00958 as new diagnostic and prognostic biomarker of childhood acute lymphoblastic leukaemia of B cells

in Hematologic Malignancies

Filomena Altieri
Lorena Buono
Mariamichela Lanzilli
Peppino Mirabelli
Alessandra Cianflone
Giuliana Beneduce
Antonia De Matteo
Rosanna Parasole
M. Salvatore
Giovanni Smaldone

Frontiers in Oncology

doi 10.3389/fonc.2024.1388154

1,418 views
1 citation

Original Research

Published on 30 May 2024

Hematopoietic stem cell transplantation: an Italian monocentric experience on the health assessment and eligibility of adult-related donors

in Hematologic Malignancies

Caterina Giovanna Valentini
Sara Ceglie
Federica Fatone
Elisabetta Metafuni
Claudio Pellegrino
Patrizia Chiusolo
Simona Sica
Luciana Teofili

Frontiers in Oncology

doi 10.3389/fonc.2024.1389068

1,199 views

Original Research

Published on 28 May 2024

Health-related quality of life in adults with hematological cancer: a 2023 cross-sectional survey from Qatar

in Hematologic Malignancies

Yasamin Abdu
Khalid Ahmed
Mariam Abdou
Rayan Elhussein
Sayda Sirelkhatim
Iheb Bougmiza
Mohamed A. Yassin
Nagah A. Selim

Frontiers in Oncology

doi 10.3389/fonc.2024.1391429

1,743 views

Case Report

Published on 28 May 2024

Case report: Difficult diagnosis of Mycobacterium tuberculosis infection in patients after allogeneic hematopoietic stem cell transplantation: two case reports and a literature review

in Hematologic Malignancies

Zhenghua Liu
Dali Cai
Nan Su

Frontiers in Oncology

doi 10.3389/fonc.2024.1283320

950 views
2 citations

Mini Review

Published on 21 May 2024

Mechanisms and management of CAR T toxicity

in Hematologic Malignancies

Christopher J. Ferreri
Manisha Bhutani

Frontiers in Oncology

doi 10.3389/fonc.2024.1396490

5,851 views
14 citations